GL1X · GenesisL1 explorer

Research workbench

Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site

Analyse Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1E1Y
Type
protein
Length
813 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
CPB, PLP, GLC, PO3
Pockets
13 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein81352% helix, 15% strandP00489

Ligands and binding sites

  • CPB · 2-(2-chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-4H-benzopyran-4-one · ligand · chains A
  • PLP · Pyridoxal-5'-phosphate · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A
  • PO3 · Phosphite ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12760.850.9648GLC, PLP
22010.770.9243empty
35330.670.7863empty
41080.520.8219empty
51170.510.8131empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1E1Y · Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.